Back to journals
Academic Journal

Nature Reviews Neuroscience

4 Papers Indexed in Blossom

Data updated

Research Footprint

Nature Reviews Neuroscience has 4 tracked papers indexed in Blossom (2010–2024) from 10 authors, most often covering MDMA, Ketamine and Psilocybin, across Depressive Disorders, Neuroimaging & Brain Measures and Adolescents.

Published Papers

Paywallmeta

Structural neural plasticity evoked by rapid-acting antidepressant interventions

This review (2024) highlights preclinical research from the past 15 years showing that ketamine and psychedelics trigger dendritic spine growth in cortical pyramidal neurons, enhancing neural plasticity. It compares the longitudinal effects of psychoactive drugs, emphasizing rapid-onset and sustained structural plasticity as key features of rapid-acting antidepressants, and discusses gaps in understanding and prospects for other interventions like rTMS.

Published
Journal
Nature Reviews Neuroscience
Authors
Liao, C., Dua, A. N., Wojtasiewicz, C., Liston, C., Kwan, A. C.
Open Accessmeta

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

This review (2020) gives a high-level overview of psychedelics and their (potential) role in the treatment of mental disorders.

Published
Journal
Nature Reviews Neuroscience
Authors
Vollenweider, F. X., Preller, K. H.
Open Accessmeta

Effects of Schedule I drug laws on neuroscience research and treatment innovation

This opinion article (2013) provides a scientific perspective on how Schedule I drug laws affect neuroscientific research using controlled substances. It shows how the legal approach to drug control has hindered research into the therapeutic potential of cannabis, stimulants, and psychedelic drugs. Moving these substances from Schedule I to Schedule II would make them more accessible for research. Still, this decision would require approval by a majority of United Nations Member States. However, preclinical research could be performed more quickly if a licensing category was created in the law, especially for scientists who need only small amounts of drugs.

Published
Journal
Nature Reviews Neuroscience
Authors
King, C., Nichols, D. E.
Paywallmeta

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

This oft-cited (457+) opinion/review article by Vollenweider & Kometer gives an overview of the neurobiology of psychedelics and where research stood in 2010.

Published
Journal
Nature Reviews Neuroscience
Authors
Vollenweider, F. X., Kometer, M.

Quick Facts

Papers Indexed
4
h-Index
493
Open Access
No
Publisher
Nature Portfolio
Country
United Kingdom
Website
Visit